Skip to main content
MedPathMedPath Home
Clinical Trials/ACTRN12613000880741
ACTRN12613000880741
Completed
未知

Catheter Ablation versus MEdical Rate control in Atrial fibrillation and heart failure – An MRI guided multi-centre randomised controlled trial – the CAMERA-MRI study.

Baker IDI Heart & Diabetes Institute0 sites66 target enrollmentAugust 7, 2013
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsAtrial FibrillationHeart FailureCardiovascular - Other cardiovascular diseases

Overview

Phase
未知
Intervention
Not specified
Conditions
Atrial Fibrillation
Sponsor
Baker IDI Heart & Diabetes Institute
Enrollment
66
Status
Completed
Last Updated
6 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
August 7, 2013
End Date
May 8, 2017
Last Updated
6 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Baker IDI Heart & Diabetes Institute

Eligibility Criteria

Inclusion Criteria

  • •Paroxysmal or persistent AF
  • •LVEF \< 45%
  • •Dilated Cadriomyopathy

Exclusion Criteria

  • •Non MRI safe Pacemaker, ICD or BiVentricular Device
  • •Renal Impairment Cr \> 200
  • •Left atrial thrombus

Outcomes

Primary Outcomes

Not specified

Similar Trials

Recruiting
Not Applicable
Treatment of tachycardia-bradycardia syndrome using radiofrequency catheter ablation of paroxysmal atrial fibrillation versus permanent pacemaker implantation: prospective, randomized trialDiseases of the circulatory system
KCT0000155Asan Medical Center88
Active, not recruiting
Not Applicable
Catheter Ablation compared with Pharmacological Therapy for Atrial Fibrillation – the CAPTAF trial - captafTo study the effect of catheter ablation (using CE marked products) on the quality of life an in patients with atrial fibrillation depsite treatment with conevntional antiarrhythmic medical therapy.atrial fibrillation is thus the disease to be investigatedMedDRA version: 9.1Level: LLTClassification code 10066664Term: Recurrent symptomatic atrial fibrillation
EUCTR2008-001384-11-SE250
Active, not recruiting
Not Applicable
Catheter Ablation Versus Antiarrhythmic Drug Therapy for Atrial Fibrillation TrialAtrial fibrillationTherapeutic area: Diseases [C] - Cardiovascular Diseases [C14]
EUCTR2011-002532-12-CZMayo Clinic3,000
Active, not recruiting
Phase 1
Catheter Ablation Versus Antiarrhythmic Drug Therapy for Atrial Fibrillation TrialAtrial fibrillationMedDRA version: 19.0Level: PTClassification code 10003658Term: Atrial fibrillationSystem Organ Class: 10007541 - Cardiac disordersTherapeutic area: Diseases [C] - Cardiovascular Diseases [C14]
EUCTR2011-002532-12-DEMayo Clinic2,200
Active, not recruiting
Phase 1
The Catheter Ablation versus Antiarrhythmic Drug Therapy for Atrial Fibrillation TrialAtrial fibrillationMedDRA version: 14.1Level: PTClassification code 10003658Term: Atrial fibrillationSystem Organ Class: 10007541 - Cardiac disordersTherapeutic area: Diseases [C] - Cardiovascular Diseases [C14]
EUCTR2011-002532-12-ITMAYO CLINIC3,000